A Double-Blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d, in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft

Trial Profile

A Double-Blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d, in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jan 2017

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Embolism and thrombosis; Peripheral arterial disorders
  • Focus Therapeutic Use
  • Acronyms CASPAR
  • Sponsors Sanofi
  • Most Recent Events

    • 30 Nov 2006 Status change
    • 07 Aug 2006 Status change
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top